HOLLYWOOD, Calif.--(BUSINESS WIRE)--ImaRx Therapeutics, Inc. (OTCBB:IMRX), a publicly traded corporation, trading under the symbol IMRX, has been transformed into a diversified, full service feature film marketing and distribution company following the acquisition by the shareholders of Sycamore Films Inc. of a controlling interest in the former healthcare company.
